Prevalence and impact of vasomotor symptoms due to menopause: Canadian subgroup of the Women with Vasomotor Symptoms Associated With Menopause (WARM) study

被引:0
|
作者
Yuksel, Nese [1 ]
Todorova, Lora [2 ]
Scrine, Ludmila [2 ]
Rea, Carol [3 ]
机构
[1] Univ Alberta, Edmonton, AB, Canada
[2] Astellas Pharma Europe Ltd, Addlestone, Surrey, England
[3] IQVIA Ltd, Reading, Berks, England
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
P-116
引用
收藏
页码:1305 / 1305
页数:1
相关论文
共 50 条
  • [41] Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden
    Nappi, Rossella E.
    Kroll, Robin
    Siddiqui, Emad
    Stoykova, Boyka
    Rea, Carol
    Gemmen, Eric
    Schultz, Neil M.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (08): : 875 - 882
  • [42] Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society
    Santoro, NF
    Clarkson, TB
    Freedman, RR
    Fugh-Berman, AJ
    Loprinzi, CL
    Reame, NK
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2004, 11 (01): : 11 - 33
  • [43] Effect of Body Mass Index on Treatment of Vasomotor Symptoms Associated with Menopause
    Ackerman, Ronald T.
    Hedrick, Richard E.
    Goracke-Postle, Cory
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1211 - 1212
  • [44] Efficacy and Safety of Fezolinetant for the Treatment of Menopause-Associated Vasomotor Symptoms
    Bonga, Krishna Nikhila
    Mishra, Archana
    Maiti, Rituparna
    Padhy, Biswa Mohan
    Meher, Bikash Ranjan
    Srinivasan, Anand
    OBSTETRICS AND GYNECOLOGY, 2024, 143 (03): : 393 - 402
  • [45] Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms
    Umland, Elena M.
    JOURNAL OF MANAGED CARE PHARMACY, 2008, 14 (03): : S14 - S19
  • [47] Fezolinetant in the treatment of vasomotor symptoms associated with menopause: a profile of its use
    Blair, Hannah A.
    DRUGS & THERAPY PERSPECTIVES, 2024, 40 (05) : 173 - 180
  • [48] Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause A Randomized Controlled Trial
    Neal-Perry, Genevieve
    Cano, Antonio
    Lederman, Samuel
    Nappi, Rossella E.
    Santoro, Nanette
    Wolfman, Wendy
    English, Marci
    Franklin, Catherine
    Valluri, Udaya
    Ottery, Faith D.
    OBSTETRICS AND GYNECOLOGY, 2023, 141 (04): : 737 - 747
  • [49] Fezolinetant for the treatment of vasomotor symptoms associated with menopause: a meta-analysis
    Chavez, Matheus Pedrotti
    Pasqualotto, Eric
    Ferreira, Rafael Oliva Morgado
    Hohl, Alexandre
    de Moraes, Francisco Cezar Aquino
    Schmidt, Pedro Henrique Siedschlag
    Rodrigues, Anna Luiza Soares de Oliveira
    de Sa, Joao Roberto
    CLIMACTERIC, 2024, 27 (03) : 245 - 254
  • [50] Prevalence and impact of vasomotor symptoms due to menopause among women in Brazil, Canada, Mexico, and Nordic Europe: a cross-sectional survey
    Todorova, Lora
    Bonassi, Rogerio
    Carreno, Francisco Javier Guerrero
    Hirschberg, Angelica L.
    Yuksel, Nese
    Rea, Carol
    Scrine, Ludmila
    Kim, Janet S.
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2023, 30 (12): : 1179 - 1189